RGLS - Regulus Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

RGLS is currently covered by 4 analysts with an average price target of $16.46. This is a potential upside of $14.68 (824.72%) from yesterday's end of day stock price of $1.78.

Regulus Therapeutics's activity chart (see below) currently has 25 price targets and 46 ratings on display. The stock rating distribution of RGLS is 94.12% BUY and 5.88% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 24.44% with an average time for these price targets to be met of 73.86 days.

Highest price target for RGLS is $28, Lowest price target is $10, average price target is $11.75.

Most recent stock forecast was given by WHITNEY IJEM from CANACCORD on 17-Mar-2025. First documented stock forecast 22-Oct-2014.

Currently out of the existing stock ratings of RGLS, 16 are a BUY (94.12%), 1 are a HOLD (5.88%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$28

$26.22 (1473.03%)

26 days ago
(17-Mar-2025)

0/2 (0%)

$26.63 (1943.80%)

Buy

$10

$8.22 (461.80%)

$10

29 days ago
(14-Mar-2025)

1/9 (11.11%)

$8.52 (575.68%)

255

Buy

$6

$4.22 (237.08%)

$240

1 years 25 days ago
(18-Mar-2024)

0/2 (0%)

$3.64 (154.24%)

Hold

$3

$1.22 (68.54%)

1 years 30 days ago
(13-Mar-2024)

1/4 (25%)

$0.57 (23.46%)

139

Hold

$4.2

$2.42 (135.96%)

$10

3 years 2 months 22 days ago
(21-Jan-2022)

3/5 (60%)

$1.96 (87.50%)

43

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is RGLS (Regulus Therapeutics) average time for price targets to be met?

On average it took 73.86 days on average for the stock forecasts to be realized with a an average price target met ratio 24.44

Which analyst has the current highest performing score on RGLS (Regulus Therapeutics) with a proven track record?

LIANA MOUSSATOS

Which analyst has the current lower performing score on RGLS (Regulus Therapeutics) with a proven track record?

JOSEPH SCHWARTZ

Which analyst has the most public recommendations on RGLS (Regulus Therapeutics)?

Liana Moussatos works at WEDBUSH and has 5 price targets and 7 ratings on RGLS

Which analyst is the currently most bullish on RGLS (Regulus Therapeutics)?

Matthew Luchini with highest potential upside - $162.62

Which analyst is the currently most reserved on RGLS (Regulus Therapeutics)?

Jim Birchenough with lowest potential downside - $1.22

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?